Compare ARTL & GVH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARTL | GVH |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.9M |
| IPO Year | N/A | 2023 |
| Metric | ARTL | GVH |
|---|---|---|
| Price | $1.42 | $1.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $30.00 | ★ $80.00 |
| AVG Volume (30 Days) | 108.0K | ★ 1.2M |
| Earning Date | 11-12-2025 | 02-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 11.95 |
| Revenue | N/A | ★ $21,878,867.00 |
| Revenue This Year | N/A | $141,706.20 |
| Revenue Next Year | N/A | $3.35 |
| P/E Ratio | ★ N/A | $0.12 |
| Revenue Growth | N/A | ★ 24.52 |
| 52 Week Low | $1.15 | $1.28 |
| 52 Week High | $28.60 | $364.00 |
| Indicator | ARTL | GVH |
|---|---|---|
| Relative Strength Index (RSI) | 40.55 | 30.20 |
| Support Level | $1.48 | $1.31 |
| Resistance Level | $1.82 | $1.58 |
| Average True Range (ATR) | 0.16 | 0.46 |
| MACD | 0.04 | -0.12 |
| Stochastic Oscillator | 39.55 | 1.37 |
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.